Trade Ocular Therapeutix Inc - OCUL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024318% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002096% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.17 |
| Open | 9.26 |
| 1-Year Change | 162.32% |
| Day's Range | 9.26 - 9.62 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 6, 2024 | 9.59 | 0.36 | 3.90% | 9.23 | 9.64 | 9.09 |
| Dec 5, 2024 | 9.17 | -0.18 | -1.93% | 9.35 | 9.54 | 9.12 |
| Dec 4, 2024 | 9.45 | 0.11 | 1.18% | 9.34 | 9.70 | 9.34 |
| Dec 3, 2024 | 9.47 | -0.22 | -2.27% | 9.69 | 10.18 | 9.38 |
| Dec 2, 2024 | 9.74 | 0.02 | 0.21% | 9.72 | 10.10 | 9.72 |
| Nov 29, 2024 | 9.87 | -0.17 | -1.69% | 10.04 | 10.13 | 9.70 |
| Nov 27, 2024 | 10.04 | 0.41 | 4.26% | 9.63 | 10.11 | 9.26 |
| Nov 26, 2024 | 9.72 | 0.69 | 7.64% | 9.03 | 9.84 | 9.03 |
| Nov 25, 2024 | 9.06 | 0.23 | 2.60% | 8.83 | 9.10 | 8.74 |
| Nov 22, 2024 | 8.80 | 0.29 | 3.41% | 8.51 | 8.84 | 8.33 |
| Nov 21, 2024 | 8.49 | -0.22 | -2.53% | 8.71 | 8.78 | 8.19 |
| Nov 20, 2024 | 8.74 | -0.12 | -1.35% | 8.86 | 8.87 | 8.54 |
| Nov 19, 2024 | 8.90 | 0.39 | 4.58% | 8.51 | 8.93 | 8.49 |
| Nov 18, 2024 | 8.66 | -0.41 | -4.52% | 9.07 | 9.11 | 8.60 |
| Nov 15, 2024 | 9.14 | -0.76 | -7.68% | 9.90 | 9.95 | 9.12 |
| Nov 14, 2024 | 9.90 | -0.58 | -5.53% | 10.48 | 10.70 | 9.80 |
| Nov 13, 2024 | 10.58 | -0.04 | -0.38% | 10.62 | 11.09 | 10.58 |
| Nov 12, 2024 | 10.59 | -0.28 | -2.58% | 10.87 | 11.03 | 10.44 |
| Nov 11, 2024 | 10.93 | -0.20 | -1.80% | 11.13 | 11.18 | 10.73 |
| Nov 8, 2024 | 11.07 | 0.30 | 2.79% | 10.77 | 11.07 | 10.55 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Ocular Therapeutix Inc Company profile
About Ocular Therapeutix Inc
Ocular Therapeutix, Inc. is a biopharmaceutical company, which is focused on the formulation, development and commercialization of therapies for diseases and conditions of the eye using its proprietary, bioresorbable hydrogel platform technology. The Company’s product pipeline candidates provide differentiated drug delivery solutions. The Company’s products include dexamethasone insert (DEXTENZA) and ReSure Sealant. Its DEXTENZA is an intracanalicular insert for the treatment of post-surgical ocular inflammation and pain. Its ReSure Sealant is an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery. The Company’s products that are in pipeline include OTX-TKI for the treatment of wet AMD, OTX-TIC for the treatment of glaucoma and ocular hypertension, OTX-CSI for the chronic treatment of dry eye disease, and OTX-DED for the short-term treatment of the signs and symptoms of dry eye disease.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Ocular Therapeutix Inc revenues increased from $17.4M to $43.5M. Net loss decreased 96% to $6.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Change in fair value of derivative liab. increase from $86.2M (expense) to $78.1M (income), Interest Expense decrease of 1% to $6.7M (expense).
| Industry: | Pharmaceuticals (NEC) |
24 Crosby Drive
BEDFORD
MASSACHUSETTS 01730
US
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
09:32, 4 December 2024
Silver price forecast 2025 and beyond: Third party price target
Rising interest rates and a strong dollar pushed silver to a two-year last September, but what lies ahead?
16:00, 3 December 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
16:41, 28 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com